KKR-backed Boots in deal with drug wholesaler AmerisourceBergen

The deal would give Walgreens and Alliance Boots the option to acquire a stake of up to 23% in the drug wholesaler, which is reported to be worth $2.5bn. Up to 7% can be bought in the open market, with a remaining 16% available for purchase at a later date.

Walgreens currently has a distribution deal with Cardinal Health, which will end in favour of a 10-year distribution deal with AmerisourceBergen. Walgreens' share price rose 5.4% after the announcement of the wholesale deal.

KKR and Axa PE made a partial exit from Alliance Boots in 2012, following a cash and shares offer from Walgreens, which acquired a 45% stake for around £4.3bn. Walgreens will have the option to buy the remaining Boots shares by 2015.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• United States
• United Kingdom
• KKR
• Axa Private Equity